GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Capital Expenditure

C-Mer Eye Care Holdings (HKSE:03309) Capital Expenditure : HK$-115.86 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

C-Mer Eye Care Holdings's cash flow for capital expenditures for the six months ended in Dec. 2023 was HK$-71 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-115.86 Mil.


C-Mer Eye Care Holdings Capital Expenditure Historical Data

The historical data trend for C-Mer Eye Care Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Capital Expenditure Chart

C-Mer Eye Care Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.91 -220.81 -129.23 -91.23 -115.86

C-Mer Eye Care Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.65 -37.69 -53.54 -44.98 -70.88

C-Mer Eye Care Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-115.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Mer Eye Care Holdings (HKSE:03309) Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.
Executives
C-mer Group Limited 2101 Beneficial owner
Lam Shun Chiu Dennis 2201 Interest of corporation controlled by you
Li Xiaoting 2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines